Uzbekistan Opens 60-Day Fast Track for Ultrasound Metrics

On June 16, 2026, Uzbekistan signaled a concrete regulatory adjustment for Ultrasound Metrics devices by introducing a green pre-review route tied to ISO 13485 and IEC 62359 compliance. The move matters not only for device manufacturers, exporters, and distributors, but also for testing, documentation, procurement, and delivery planning, because it shortens the stated registration timeline and recognizes certain Chinese regulatory and testing documents as equivalent technical materials.

A narrower and faster registration route is now defined

According to the announced information, the Ministry of Health of Uzbekistan and the national drug regulator UzPharm jointly introduced a green pre-review channel for eligible Ultrasound Metrics devices on June 16, 2026.

The eligible scope includes portable ultrasound systems, elastography modules, and AI-assisted measurement kits, provided that the devices meet ISO 13485 and IEC 62359 standards.

Under this route, the registration cycle is reduced to 60 calendar days. The announcement also states that a China NMPA registration certificate together with a CNAS test report can be accepted as equivalent technical documentation.

The first batch is limited to 200 registration numbers, and applications are scheduled to open in Q3 2026.

Where the rule change may be felt first

Manufacturers and export teams may reassess market-entry sequencing

For manufacturers and export-facing teams, the main impact is at the market-entry stage. A shorter stated registration period may change how companies prioritize product launches, especially for device categories explicitly covered by the announcement. What deserves closer attention is whether internal compliance files already align with the stated ISO 13485 and IEC 62359 requirements, because the faster route appears to depend on that baseline.

Documentation and testing functions may gain operational importance

For regulatory affairs teams, testing service providers, and certification-related firms, the acceptance of an NMPA registration certificate plus a CNAS test report as equivalent technical documentation may affect how submission packages are assembled. The practical issue is not only whether the documents exist, but whether their format, scope, and technical correspondence match the expectations of the Uzbek review process once applications open.

Distributors and procurement parties may adjust timing and supplier screening

For distributors, healthcare buyers, and procurement planners, the announced 60-day cycle and the first-batch cap of 200 registration numbers may influence supplier qualification and purchasing schedules. From an industry perspective, this could shift attention toward whether a supplier is already prepared for the fast-track window, whether the covered product category clearly fits the announced scope, and whether documentation readiness affects delivery commitments.

After-sales and supply chain participants should watch traceability expectations

For supply chain service providers and after-sales partners, the announcement may affect delivery coordination, technical file handover, and product traceability preparation. Analysis shows that when review timelines are compressed, inconsistencies between registration files, shipped configurations, and service documentation can become more visible, so alignment across compliance, logistics, and post-market support deserves attention.

What companies should prepare before the Q3 window opens

Check whether the product really fits the announced category

Companies should first verify whether their products fall within the stated Ultrasound Metrics scope, including portable ultrasound devices, elastography modules, or AI-assisted measurement kits. This is especially important where integrated systems include multiple modules and the product description used in filings, bids, or commercial documents may affect how eligibility is interpreted.

Review technical files against the stated equivalence pathway

Firms planning to rely on the NMPA certificate and CNAS report pathway should review whether those materials are current, internally consistent, and suitable for cross-border submission. Observably, the announcement confirms acceptance in principle, but it does not, based on the provided information, resolve every execution detail around document format, translation, supporting annexes, or review interpretation.

Plan around quota pressure rather than assuming open access

The first-batch limit of 200 registration numbers means companies should not treat the channel as unlimited capacity. What deserves closer attention is application timing, internal approval speed, and readiness of supporting materials, because quota constraints can turn documentation delays into a commercial issue affecting launch schedules and distributor coordination.

Keep procurement and delivery promises conservative

Sales, channel, and operations teams should be careful not to convert a policy signal into unconditional delivery commitments too early. From an industry perspective, the route appears operationally meaningful, but businesses still need to watch how the application process opens in Q3 2026 and whether procurement documents or local review practice add further requirements.

Why this looks like an execution signal, not just a headline

Analysis shows that this announcement is more than a general policy statement because it identifies eligible product types, references specific standards, states a 60-day registration cycle, and names a document-equivalence route involving NMPA and CNAS materials. At the same time, it is more appropriate to understand this as an execution signal with defined entry conditions rather than as a fully settled market opening for all ultrasound-related products.

Observably, the most important follow-up issue is not whether the policy exists, but how consistently it will be implemented once Q3 applications begin. Industry participants should therefore continue to monitor later official wording, filing practice, and any changes in procurement or technical documentation requirements.

How the market may read this at the current stage

At this stage, the development can be read as a targeted easing of registration access for a defined group of Ultrasound Metrics devices, with implications for compliance preparation, trade timing, and supplier readiness. It does not by itself confirm final approval outcomes, broader category expansion, or uniform execution across every transaction and product configuration.

A rational reading is that the rule change creates a potentially shorter and more document-efficient path for qualified applicants, while leaving enough operational details open that companies should prepare carefully and continue to verify execution conditions as the application window approaches.

Basis of this article and what still needs verification

This article is generated from the user-provided news title, event date, and event summary. For developments of this type, relevant source categories usually include official notices, regulator releases, trade or customs authority information, industry association updates, standards documentation, and reporting from established professional media.

No specific official source link was provided in the input, so the exact official publication path still needs to be verified on an ongoing basis. Further observation should focus on implementing details, certification and documentation interpretation, any change in tender or procurement wording, market feedback, and how companies actually execute filings under the announced channel.